North America, led primarily by the United States and supported by Canada’s growing biotechnology sector, continues to dominate the global biopharmaceutical manufacturing landscape. The region benefits from strong government funding initiatives, a highly skilled workforce, and a robust pipeline of biologic drug development projects. Expansion of contract development and manufacturing...